Abstract
Cancer cells exhibit a remarkable ability to orchestrate metabolic adaptations to survive and proliferate. Such metabolic adaptations, including carbohydrates, amino acids and lipid metabolism, have been shown to also contribute to the pathological cascade during cancer progression and therapy resistance. Importantly, these adaptations provide a rational for targeted therapies inducing selective cell death. Recently, two studies by Lorito et al (Lorito et al, 2024) and Ackermann et al (Ackermann et al, 2024) published in EMBO Molecular Medicine reported examples of alterations in lipid metabolism that can promote targetable vulnerabilities for tumors with poor prognosis.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callSimilar Papers
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
